Combination antimicrobial therapy to manage resistance
Open Access
- 1 January 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Evolution, Medicine, and Public Health
- Vol. 11 (1) , 185-186
Abstract
The concurrent use of multiple antimicrobials to treat patients is common in clinical practice. Combination therapy is used for many reasons, the majority of which have little to do with antimicrobial resistance [ 1]. However, combination therapy impacts both the likelihood and the nature of resistance evolution, thus it has been a major focus of ‘resistance management strategies’ aimed at alleviating the global antimicrobial resistance crisis.Keywords
This publication has 4 references indexed in Scilit:
- Bystander Selection for Antimicrobial Resistance: Implications for Patient HealthTrends in Microbiology, 2019
- Multidrug evolutionary strategies to reverse antibiotic resistanceScience, 2016
- EMERGENCE OF ISONIAZID-RESISTANT CULTURES IN PATIENTS WITH PULMONARY TUBERCULOSIS DURING TREATMENT WITH ISONIAZID ALONE OR ISONIAZID PLUS PAS1964
- TREATMENT OF PNEUMOCOCCIC MENINGITIS WITH PENICILLIN COMPARED WITH PENICILLIN PLUS AUREOMYCINA.M.A. Archives of Internal Medicine, 1951